Cargando…
Need for an Update for the Guideline for the Management of Mild Cognitive Impairment
Attention is being paid to diagnosis and treatment of mild cognitive impairment (MCI) because early diagnosis and preventive management can slow down the progression of Alzheimer’s disease. In particular, in the present era, the use of biomarkers for predicting conversion into dementia is permitted...
Autores principales: | Kim, Minji, Moon, So Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Dementia Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644063/ https://www.ncbi.nlm.nih.gov/pubmed/36407292 http://dx.doi.org/10.12779/dnd.2022.21.4.107 |
Ejemplares similares
-
Are Guidelines Needed for the Diagnosis and Management of Incipient Alzheimer's Disease and Mild Cognitive Impairment?
por: Palmer, Katie, et al.
Publicado: (2010) -
New Trends in Cognitive Aging and Mild Cognitive Impairment
por: Facal, David, et al.
Publicado: (2022) -
Nationally Informed Recommendations on Approaching the Detection, Assessment, and Management of Mild Cognitive Impairment
por: Woodward, Michael, et al.
Publicado: (2022) -
Mild Cognitive Impairment: Beyond Memory Dysfunction
por: Tales, Andrea, et al.
Publicado: (2012) -
Risk Factors for Mild Cognitive Impairment (MCI)
por: Loftus, Andrea Mary
Publicado: (2017)